Cel-Sci Operating Income

As of the most recent data (June 2026), CVM shows a operating income of $-11M. That compares with $-19M in the prior-year period — up 38.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CVM's operating income is now $-11M (was $-19M) — a 38.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Cel-Sci is outperforming or lagging.

Tracking CVM's operating income over time shows whether Cel-Sci is scaling, shrinking, or reshaping that part of the business. The current reading is $-11M That compares with $-19M in the prior-year period — up 38.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Cel-Sci's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-11M) with ownership activity and broader fundamentals.

Cel-Sci's operating income is $-11M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.